Avantor, Inc. Common Stock (AVTR)

10.28
+0.20 (1.93%)
NYSE· Last Trade: Jun 26th, 11:54 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · June 26, 2026
Why Avantor (AVTR) Stock Is Up Today
What Happened? Shares of life sciences company Avantor (NYSE:AVTR) jumped 3.2% in the morning session after an analyst at Barclays boosted their price target...
Via StockStory · June 25, 2026
3 Unprofitable Stocks We Approach with Caution
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Via StockStory · June 25, 2026
Q1 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Avantor (NYS...
Via StockStory · June 18, 2026
Avantor (AVTR) Surges After Smashing Q1 Estimateschartmill.com
Via Chartmill · April 29, 2026
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Via StockStory · June 16, 2026
Avantor (AVTR): Buy, Sell, or Hold Post Q1 Earnings?
What a brutal six months it’s been for Avantor. The stock has dropped 30.3% and now trades at $7.66, rattling many shareholders. This might have investors co...
Via StockStory · May 20, 2026
5 Must-Read Analyst Questions From Avantor’s Q1 Earnings Call
Avantor's first quarter results were met with a negative market reaction, as investors focused on persistent margin pressures and flat revenue growth. Manage...
Via StockStory · May 6, 2026
AVTR Q1 Deep Dive: Leadership Changes, Segment Stabilization, and Execution Drive Outlook
Life sciences company Avantor (NYSE:AVTR) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $1.58 billion. Its non-GAA...
Via StockStory · April 30, 2026
Avantor (AVTR) Q1 2026 Earnings Transcriptfool.com
Avantor (AVTR) Q1 2026 Earnings Transcript
Via The Motley Fool · April 29, 2026
Avantor’s (NYSE:AVTR) Q1 CY2026 Sales Beat Estimates
Life sciences company Avantor (NYSE:AVTR) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.58 bi...
Via StockStory · April 29, 2026
Avantor (AVTR) Q1 Earnings: What To Expect
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Avantor beat analysts’ revenu...
Via StockStory · April 27, 2026
What Olstein's Korn Ferry Add Might Signal About Betting on a Hiring Recoveryfool.com
Korn Ferry delivers organizational consulting and talent solutions to corporations and institutions worldwide.
Via The Motley Fool · April 22, 2026
Olstein Capital Sells $5.2 Million Kulicke and Soffa Stake -- Is the Semiconductor Equipment Rally Over?fool.com
This semiconductor equipment maker delivers assembly and packaging solutions to electronics manufacturers across the U.S. and Asia/Pacific.
Via The Motley Fool · April 22, 2026
Avantor (AVTR) Q3 2025 Earnings Transcriptfool.com
Avantor (AVTR) Q3 2025 Earnings Transcript
Via The Motley Fool · April 21, 2026
Research Tools & Consumables Stocks Q4 In Review: Avantor (NYSE:AVTR) Vs Peers
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Avantor (NYS...
Via StockStory · April 14, 2026
3 Value Stocks That Concern Us
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via StockStory · April 14, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...
Via StockStory · April 7, 2026
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via StockStory · March 27, 2026
3 Cash-Producing Stocks We Keep Off Our Radar
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · March 26, 2026
3 of Wall Street’s Favorite Stocks We’re Skeptical Of
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · March 23, 2026
Why a $3.5 Million Bet Targets Avantor Amid a 54% Stock Dropfool.com
Avantor delivers laboratory materials and specialized services to biopharma, healthcare, and advanced technology sectors worldwide.
Via The Motley Fool · March 22, 2026
This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stockfool.com
Avantor delivers laboratory materials and specialized services to biopharma, healthcare, and advanced technology clients worldwide.
Via The Motley Fool · March 16, 2026
Avantor (AVTR): Buy, Sell, or Hold Post Q4 Earnings?
Avantor has gotten torched over the last six months - since September 2025, its stock price has dropped 38% to a new 52-week low of $7.88 per share. This may...
Via StockStory · March 16, 2026
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Via StockStory · March 6, 2026